Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation (Q58910044)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Luca Arcaini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Paolo Bernasconi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Daniela Pietra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Eloisa Arbustini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

E Rumi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C Elena

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

A Brisci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Cazzola

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Lazzarino

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

7 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

798-800

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

A gain-of-function mutation of JAK2 in myeloproliferative disorders

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.231

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.231

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.231

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.231

Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.231

7 January 2021

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.231

7 January 2021

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.231

7 January 2021

A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.231

7 January 2021

Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.231

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19734947%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference